Figure 5.
Osa-miR172d-5p suppressed Tab1 upregulation in a bleomycin-induced fibrosis model. (A, B) C57BL male mice were treated with bleomycin (1 mg/kg bw intratracheal administration); after 1 week, the bleomycin-treated mice were treated with the negative control miR (3 nmol/mouse 5 times in 2 weeks, intraperitoneal injection with AteloGene) or miR Osa-miR172d-5p mimic miR (3 nmol/mouse five times in 2 weeks, intraperitoneal injection with AteloGene). After 3 weeks, the mice were sacrificed, their lung tissues were harvested, and fibrosis was assessed through the immunofluorescence analysis of Tab1 in mouse lungs (n = 5, 5, 4). (C) Correlation was performed via Spearman’s rank test (n = 14). Data are shown as mean ± SEM. **P < 0.01. ***P < 0.001 vs. control group.